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The double-edged sword of mechanical  
ventilation for patients with cardiogenic shock
Dr Lazzeri et al. [1] should be congratulated for 
their description of patients treated by percutaneous 
coronary reperfusion for ST elevation myocardial 
infarction (STEMI). They concluded that mechanical 
ventilation (MV) was an independent factor of short 
and long term mortality with quantitative relation-
ship between MV duration and Intensive Care Unit 
mortality. However, quantitative relationship does 
not make causality. Furthermore, despite multi-
variate regression and propensity score analyses, 
their results are obscured by the most important 
missing variable, namely cardiogenic shock (CS) [2]. 
Reasons for intubation were ventricular fibrillation 
in 32 (30%) patients, pulmonary edema in 10 (10%) 
patients, and CS in 64 (60%) patients. In order to 
correct this bias, cardiac arrest and CS should have 
been introduced (or forced) into the model.
MV remained independently associated with 
mortality but not Killip class (a proxy for heart fai-
lure [HF]). However, these results deserve scrutiny 
as some patients may have been misclassified. The 
number of patients with Killip class III–IV receiving 
MV is 64, which is hardly possible with 64 patients 
with CS + 10 patients with acute pulmonary edema. 
From the 89 patients with Killip class III–IV who did 
not receive MV, only few must have suffered from 
CS as almost 7% of such STEMI patients present 
with CS in the literature and most of them must 
have received MV in their cohort: 64/1294 (5%) [2].
The precise role of MV in ventilator and hemo-
dynamic assistance of patients with CS is sparse and 
not discussed in the paper. CS is characterized by low 
cardiac output along with decreased systemic vascu-
lar resistance: a stereotype of delivery/consumption 
(DO2/VO2) dependency. In order to improve this 
equation, means that increase DO2 or decrease VO2 
are considered [3]. Unfortunately, most of treatments 
increasing DO2 have deleterious effects on outcome. 
Several means have the ability to decrease VO2 with 
various effects on outcome including:
1.  Pain control but opiates have been associated 
with increased mortality in HF cohorts. 
2.  Lowering body temperature, which has been 
proved to limit infarct size and proposed for 
patients with CS.
3.  Various degree of anxiolysis from light to 
profound sedation (± curarization) and MV 
that suppress respiration efforts accounting 
for 10–25% of global VO2.
However, MV has been consistently associated 
with nosocomial infection (including pneumonia in 
23 of their patients), prolonged hospital stay and 
mortality. MV is hardly dissociable from treatments 
given for sedation and analgesia. Those agents (inclu-
ding propofol and remifentanyl used in their patients) 
have deleterious hemodynamic effects by decreasing 
already altered vascular resistance and immunologic 
effects, promoting infections. This could be counter-
balanced by choosing a “cardio protective” analgo-
-sedative agent, for example volatile anesthetics. 
Moreover, positive pressure ventilation improves 
performances of dilated left ventricles with elevated 
filling pressure. To my knowledge, prognostic impact 
of MV in patients with CS is still not known. However, 
I would suggest reserving MV for [4]: (1) alteration 
of consciousness; (2) severe respiratory distress; 
(3) profound lactic acidosis; (4) rhythmic storm.
We don’t need study to suggest that MV should 
be withheld in any patients, until not necessary. 
However, the risk/benefit of MV and its accom-
panying treatments is to be balanced in patients 
presenting with CS with no other definitive reason 
for receiving MV.
Conflict of interest: none declared
References
 1. Lazzeri C, Valente S, Chiostri M, Attanà P, Mattesini A, Gensini GF. 
Mechanical ventilation in the early phase of ST elevation myocar-
dial infarction treated with mechanical revascularization. Cardiol J, 
2013; 20: 612–617. 
 2. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. 
Temporal trends in cardiogenic shock complicating acute myo-
cardial infarction. N Engl J Med, 1999; 340: 1162–1168.
 3. Caille V, Squara P. Oxygen uptake-to-delivery relationship: A way 
to assess adequate flow. Crit Care, 2006;10 (suppl. 3): S4. 
 4. Lesage A, Ramakers M, Daubin C et al. Complicated acute myo-
cardial infarction requiring mechanical ventilation in the intensive 
care unit: Prognostic factors of clinical outcome in a series of 
157 patients. Crit Care Med, 2004; 32: 100–105.
Sébastien Champion, MD
Réanimation médicale et toxicologique hôpital 
Lariboisière, 2 rue A. Paré, 75010 Paris, France
e-mail: champion.seb@wanadoo.fr
